CYP2D6 polymorphisms influence tamoxifen treatment outcomes in

PDF] Does CYP2D6 Genotyping have a Role in Guiding Tamoxifen Therapy

Influence of CYP2D6 and CYP2C9 polymorphisms on steady-state plasma

The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer

Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?, Expert Reviews in Molecular Medicine

SciELO - Brasil - Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer Impactos do polimorfismo genético do citocromo P450 2D6 (CYP2D6) na terapia com tamoxifeno para

Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment - Stefan A. J. Buck, C. Louwrens Braal, Maaike M. Hofman, Esther Oomen-de Hoop, Peter de Bruijn

Frontiers Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen

Cancers, Free Full-Text

Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review, BMC Cancer

CYP2D6 polymorphisms and tamoxifen adverse effects - Video Abstract ID 126557

The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian b

Pharmacogenetics and Psychiatric Care: A Review and Commentary

Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer, Egyptian Journal of Medical Human Genetics